October 2, 1991 |
I have a chronic dull ache around the left side of my breastbone, which sometimes radiates to my shoulder. What could cause this, and what treatment would you recommend? There are many causes of chronic chest pain. Two of the most common are costochondritis (inflammation of the cartilage attaching the ribs to the sternum or breastbone) and intercostal myalgia (an irritation of the muscles between the ribs). These diagnoses are often difficult to establish because the pains are vague and there are no confirming lab tests.
June 30, 2011 |
WASHINGTON - Nearly a third of Americans experience long-lasting pain - the kind that lingers for weeks to months - and too often feel stigma rather than relief from a health-care system poorly prepared to treat them, the Institute of Medicine said Wednesday. The staggering tab: Chronic pain is costing the nation at least $558 billion a year in medical bills, sick days, and lost productivity, the report found. That's more than the cost of heart disease, the No. 1 killer. All kinds of ailments can trigger lingering pain, from arthritis to cancer, spine problems to digestive disorders, injuries to surgery.
January 18, 2001 |
The Bucks County commissioners approved a contract yesterday that would allow doctors to prescribe physical therapy, acupuncture, chiropractic services and other nonmedicinal treatment to prison inmates who suffer from chronic pain, despite strong reservations voiced by the chairman. County health officials, who oversee inmates' medical treatment, say the alternative treatment will save the county money because it will reduce physician fees and will cut the growing costs of prescription drugs.
June 15, 2012
Chase Utley, who has missed all of the Phillies' season so far while recovering from chronic pain in both of his knees, played his third rehab game as a designated hitter with the single-A Clearwater Threshers on Thursday. Here is how he's done so far. AB H BB K 2B 3B HR RBI R Tuesday 5 0 0 3 0 0 0 0 0 Wednesday 5 1 0 0 0 0 0 1 2 Thursday 3 0 2 0 0 0 0 0 0 TOTALS 13 1 2 3 0 0 0 1 2
July 12, 2014 |
State and medical organization officials released new guidelines Thursday for prescribing opioids, one of the first concrete steps that Pennsylvania has taken to address an overdose death rate that ranks among the worst in the nation. After months of discussion, collaboration, and compromise, a large task force requested by Gov. Corbett last fall announced the recommendations to help doctors responsibly prescribe narcotic painkillers. "The guidelines have a twofold mission," said Physician General Carrie DeLone, a task force cochair.
April 20, 2011 |
Many medical stories recently have discussed the issue of pain management. A Consumer Reports survey reported a particularly compelling finding: 97 percent of doctors polled thought they were at least somewhat effective at minimizing pain and discomfort. Within that group, 37 percent said they were "very effective. " Unfortunately, the difference between "very" and "somewhat" is anything but minor. Individual patients suffer needlessly, and that suffering has an effect on a larger scale.
June 24, 2012 |
Chase Utley is headed north from Florida and could be activated by the Phillies as soon as Wednesday, according to a report. Comcast SportsNet's Jim Salisbury, citing an unnamed source, reported late Saturday that Utley would finish the last stage of his rehab in the Philadelphia area, possibly including a game with triple-A Lehigh Valley. Utley, who has not played with the Phils this season because of chronic pain in his knees, started his second straight game at second base for the Clearwater Threshers on Saturday.
April 14, 2008 |
Cephalon Inc., of Frazer, said today that its oral medication to treat breakthrough cancer pain has received European regulatory approval. The medicine is an oral formulation of the pain therapy fentanyl for adult patients who already take an opioid medicine, such as morphine or Percocet, for underlying chronic pain. The drug, called Effentora in Europe, was approved in the United States in September 2006 under the name Fentora. Cephalon said that approval by the European regulatory commission means the biopharmaceuticals company can sell the treatment in the 27 states within the European Union.
March 21, 2006 |
Merck & Co. Inc. announced it would buy rights to promising compounds that treat pain and other neurological disorders - in a deal worth up to $475 million - from Neuromed Pharmaceuticals Ltd., a Conshohocken company developing pain medicines. The companies said yesterday that Merck would pay an initial $25 million for exclusive rights to Neuromed's experimental drugs, including Neuromed's lead compound, NMED-160, a calcium channel blocker to treat chronic pain in mid-stage Phase 2 clinical trials.
November 1, 2005 |
It might be hard to believe, but only in the past 20 years has care based on evidence become a major focus for the medical community, said Jeffery Lerner, chief executive of Plymouth Meeting-based ECRI. The nonprofit research agency, which tests the claims of medical devices, research and practices, is looking for facts in the subjective realm of pain management. Starting today, ECRI is hosting a conference on the evidence, or lack thereof, in treating chronic pain and the use of such drugs as Oxycontin and other potentially addictive painkillers.